NCT07476443 2026-03-17
VitC-CoQ10
Ain Shams University
Phase 2/3 Not yet recruiting
Clinical Trials
15 trialsNCT03435796 2026-03-04
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Celgene
Phase 2/3 Recruiting
NCT07005102 2026-01-23
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
Phase 2/3 Recruiting
NCT07279792 2025-12-29
Implications of Post-Operative Irrigation Fluid's Osmolarity on the Recurrence of Non-Muscle Invasive Bladder Cancer Following Transurethral Resection
Ain Shams University
Phase 2/3 Completed
NCT05694013 2025-10-22
ORIGAMA
Hoffmann-La Roche
Phase 2/3 Terminated
NCT05749302 2024-03-29
Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2/3 Recruiting
NCT06103279 2023-10-26
Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin
Ain Shams University
Phase 2/3 Unknown
NCT05636566 2022-12-05
Comparing TIVA Using Propofol or Dexmedetomidine Versus Sevoflurane During Anaesthesia of Children Undergoing Bone-Marrow Aspiration
Alexandria University
Phase 2/3 Completed
NCT04741880 2021-07-30
ELSA
Instituto Nacional de Cancer, Brazil
Phase 2/3 Unknown
NCT04060472 2019-08-19
Paclitaxel (Albumin-bound) and Oxaliplatin for Advanced Hepatobiliary and Malignant Tumors
Third Military Medical University
Phase 2/3 Unknown
NCT01052051 2019-07-24
CAPS
Creighton University
Phase 2/3 Completed
NCT02116803 2018-03-01
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective
Novartis
Phase 2/3 Completed
NCT02777788 2017-10-10
TCM
Shanghai University of Traditional Chinese Medicine
Phase 2/3 Unknown
NCT02250872 2016-04-20
Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury
Seoul National University Bundang Hospital
Phase 2/3 Unknown
NCT01706627 2012-10-15
MIRCIT
Khon Kaen University
Phase 2/3 Completed